Temperature Controlled LogisticsContract Pharma Features Cryoport Growth and Innovation
Contract Pharma Features Cryoport Growth and Innovation
June 23, 2020
A new Contract Pharma article is all about Cryoport!
The author interviews Mark Sawicki, Chief Commercial Officer and Phil Wilson, Senior Vice President of Global Operations & Supply Chain, who discusses the company's rapid growth alongside the growing cell and gene therapy market, how the global pandemic of COVID-19 is affecting our clients from both a clinical and commercial standpoint, and how we're providing innovative new services, including the first and only validated cleaning and disinfection process in the life sciences industry, Veri-Clean™.
Contract Pharma concludes: "Simply put, without them [Cryoport], new cell and gene therapies can't be developed, or more importantly, delivered to the patients who need them most."